Drug Profile
ONO 4057
Alternative Names: LB 457; ONO-4057Latest Information Update: 01 Jun 2011
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical
- Class Anti-inflammatories; Antipsoriatics; Phenylpropionates
- Mechanism of Action Leukotriene B4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Behcet's syndrome; Gastritis; Ulcerative colitis
Most Recent Events
- 01 Jun 2011 Discontinued - Phase-II for Behcet's syndrome in Japan (PO)
- 01 Jun 2011 Discontinued - Phase-II for Ulcerative colitis in Japan (PO)
- 01 Jun 2011 Discontinued - Preclinical for Gastritis in Japan (PO)